Standard
Switching from insulin to oral sulfonylureas in patients with diabetes due to Kir6.2 mutations. / Pearson, E.R.; Flechtner, I.; Njolstad, P.R.; Malecki, M.T.; Flanagan, S.E.; Larkin, B.; Ashcroft, F.M.; Klimes, I.; Codner, E.; Iotova, V.; Slingerland, A.S.; Shield, J.; Robert, J.; Holst, J.J.; Clark, P.M.; Ellard, S.; Sovik, O.; Polak, M.; Hattersley, A.T.
I:
New England Journal of Medicine, Bind 355, Nr. 5, 2006, s. 467-477.
Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › fagfællebedømt
Harvard
Pearson, ER, Flechtner, I, Njolstad, PR, Malecki, MT, Flanagan, SE, Larkin, B, Ashcroft, FM, Klimes, I, Codner, E, Iotova, V, Slingerland, AS, Shield, J, Robert, J, Holst, JJ, Clark, PM, Ellard, S, Sovik, O, Polak, M & Hattersley, AT 2006, 'Switching from insulin to oral sulfonylureas in patients with diabetes due to Kir6.2 mutations', New England Journal of Medicine, bind 355, nr. 5, s. 467-477.
APA
Pearson, E. R., Flechtner, I., Njolstad, P. R., Malecki, M. T., Flanagan, S. E., Larkin, B., Ashcroft, F. M., Klimes, I., Codner, E., Iotova, V., Slingerland, A. S., Shield, J., Robert, J., Holst, J. J., Clark, P. M., Ellard, S., Sovik, O., Polak, M., & Hattersley, A. T. (2006). Switching from insulin to oral sulfonylureas in patients with diabetes due to Kir6.2 mutations. New England Journal of Medicine, 355(5), 467-477.
Vancouver
Pearson ER, Flechtner I, Njolstad PR, Malecki MT, Flanagan SE, Larkin B o.a. Switching from insulin to oral sulfonylureas in patients with diabetes due to Kir6.2 mutations. New England Journal of Medicine. 2006;355(5):467-477.
Author
Pearson, E.R. ; Flechtner, I. ; Njolstad, P.R. ; Malecki, M.T. ; Flanagan, S.E. ; Larkin, B. ; Ashcroft, F.M. ; Klimes, I. ; Codner, E. ; Iotova, V. ; Slingerland, A.S. ; Shield, J. ; Robert, J. ; Holst, J.J. ; Clark, P.M. ; Ellard, S. ; Sovik, O. ; Polak, M. ; Hattersley, A.T. / Switching from insulin to oral sulfonylureas in patients with diabetes due to Kir6.2 mutations. I: New England Journal of Medicine. 2006 ; Bind 355, Nr. 5. s. 467-477.
Bibtex
@article{1020094070ec11dcbee902004c4f4f50,
title = "Switching from insulin to oral sulfonylureas in patients with diabetes due to Kir6.2 mutations",
abstract = "Udgivelsesdato: 2006/8/3",
author = "E.R. Pearson and I. Flechtner and P.R. Njolstad and M.T. Malecki and S.E. Flanagan and B. Larkin and F.M. Ashcroft and I. Klimes and E. Codner and V. Iotova and A.S. Slingerland and J. Shield and J. Robert and J.J. Holst and P.M. Clark and S. Ellard and O. Sovik and M. Polak and A.T. Hattersley",
year = "2006",
language = "English",
volume = "355",
pages = "467--477",
journal = "New England Journal of Medicine",
issn = "0028-4793",
publisher = "Massachusetts Medical Society",
number = "5",
}
RIS
TY - JOUR
T1 - Switching from insulin to oral sulfonylureas in patients with diabetes due to Kir6.2 mutations
AU - Pearson, E.R.
AU - Flechtner, I.
AU - Njolstad, P.R.
AU - Malecki, M.T.
AU - Flanagan, S.E.
AU - Larkin, B.
AU - Ashcroft, F.M.
AU - Klimes, I.
AU - Codner, E.
AU - Iotova, V.
AU - Slingerland, A.S.
AU - Shield, J.
AU - Robert, J.
AU - Holst, J.J.
AU - Clark, P.M.
AU - Ellard, S.
AU - Sovik, O.
AU - Polak, M.
AU - Hattersley, A.T.
PY - 2006
Y1 - 2006
N2 - Udgivelsesdato: 2006/8/3
AB - Udgivelsesdato: 2006/8/3
M3 - Journal article
VL - 355
SP - 467
EP - 477
JO - New England Journal of Medicine
JF - New England Journal of Medicine
SN - 0028-4793
IS - 5
ER -
